|
Condition |
Distinguishing features |
|
Guillain-Barré syndromea |
History of recent infection; paresthesias; frequently ascending paralysis; early deep areflexia; in advanced disease elevated CSF protein levels; abnormal EMG results |
|
Myasthenia gravis |
Recurrent paresis; abnormal EMG results; sustained response to cholinesterase inhibitors |
|
Stroke |
Frequently asymmetric paresis; CNS abnormalities observed on neuroimaging studies |
|
Poisoning with substances having neurodepressant effectsb |
History of exposure to toxic agents; high levels of drugs or toxins in body fluids |
|
Lambert-Eaton syndrome |
Increased muscle strength with prolonged contraction; confirmed small cell lung cancer; EMG results similar to botulism |
|
CNS infectionsc |
Altered mental status; CNS abnormalities on neuroimaging studies and EEG; abnormal CSF |
|
CNS tumor |
Frequently asymmetric paresis; CNS abnormalities on neuroimaging studies |
|
Inflammatory myopathies |
Increased creatine kinase levels |
|
Complications of diabetes mellitus |
Sensory neuropathy; paresis involving only few cranial nerves |
|
Hypothyroidism |
Abnormal test results |
|
a Including variants of Guillain-Barré syndrome, particularly Miller-Fisher syndrome. b For instance, acute ethyl alcohol intoxication, poisoning with organic phosphates, carbon monoxide, nerve gas, magnesium. c Particularly involving the brainstem. | |
|
CNS, central nervous system; CSF, cerebrospinal fluid; EEG, electroencephalography; EMG, electromyography. | |